Merck sued over expired anti-cancer patent

28-01-2016

Merck sued over expired anti-cancer patent

Light And Dark Studio / Shutterstock.com

PDL BioPharma has sued Merck Sharp & Dohme (MSD) in a complaint that centres on a now-expired patent directed to treating melanoma.


Merck Sharp & Dohme, patent infringement, PDL BioPharma, Keytruda, melanoma, US District Court for the District of New Jersey

LSIPR